After months of back and forth, Mereo and its biggest stockholder reach truce, replace board members

Lei Lei Wu

News Reporter

For months, UK biotech Mereo BioPharma has faced demands from its largest stockholder Rubric Capital Management to shake up its board and explore alternatives for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

After months of back and forth, Mereo and its biggest stockholder reach truce, replace board members

Lei Lei Wu

News Reporter

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Altos Labs buys anti-aging startup Dorian Therapeutics

Genentech expands deal with molecular glue biotech Orionis for $105M upfront

How PureTech’s lung fibrosis drug stacks up against the competition

Cocaine vaccine, a longshot attempt to quell cravings, yields mixed data in small study

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Af­ter months of back and forth, Mereo and its biggest stock­hold­er reach truce, re­place board mem­bers

News Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

After months of back and forth, Mereo and its biggest stockholder reach truce, replace board members